These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9521710)

  • 1. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
    Ruf A; de Murcia G; Schulz GE
    Biochemistry; 1998 Mar; 37(11):3893-900. PubMed ID: 9521710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
    Ruf A; Rolli V; de Murcia G; Schulz GE
    J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.
    Han S; Craig JA; Putnam CD; Carozzi NB; Tainer JA
    Nat Struct Biol; 1999 Oct; 6(10):932-6. PubMed ID: 10504727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
    Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
    J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure of ADP-ribosylating enzyme and DNA repair].
    Uchida K
    Nihon Rinsho; 1993 Nov; 51(11):3051-61. PubMed ID: 8277589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.
    Ruf A; Mennissier de Murcia J; de Murcia G; Schulz GE
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7481-5. PubMed ID: 8755499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
    Han S; Tainer JA
    Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based modeling of NAD binding to the catalytic subunits of diphtheria and pertussis toxins.
    Cummings MD; Hart TN; Read RJ
    Proteins; 1998 May; 31(3):282-98. PubMed ID: 9593199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of an NAD kinase from Archaeoglobus fulgidus in complex with ATP, NAD, or NADP.
    Liu J; Lou Y; Yokota H; Adams PD; Kim R; Kim SH
    J Mol Biol; 2005 Nov; 354(2):289-303. PubMed ID: 16242716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif.
    Tao Z; Gao P; Hoffman DW; Liu HW
    Biochemistry; 2008 May; 47(21):5804-13. PubMed ID: 18452307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scintillation proximity assay for poly(ADP-ribose) polymerase.
    Cheung A; Zhang J
    Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding mode of novel 1-substituted quinazoline derivatives to poly(ADP-ribose) polymerase-catalytic domain, revealed by X-ray crystal structure analysis of complexes.
    Matsumoto K; Kondo K; Ota T; Kawashima A; Kitamura K; Ishida T
    Biochim Biophys Acta; 2006 May; 1764(5):913-9. PubMed ID: 16631419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of mono(ADP-ribosyl)ated poly(ADP-ribose) polymerase.
    Mendoza-Alvarez H; Alvarez-Gonzalez R
    Biochemistry; 1999 Mar; 38(13):3948-53. PubMed ID: 10194306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
    Papeo G; Forte B; Orsini P; Perrera C; Posteri H; Scolaro A; Montagnoli A
    Expert Opin Ther Pat; 2009 Oct; 19(10):1377-400. PubMed ID: 19743897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins.
    Marsischky GT; Wilson BA; Collier RJ
    J Biol Chem; 1995 Feb; 270(7):3247-54. PubMed ID: 7852410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose)-polymerase-catalyzed hydrolysis of NAD+: QM/MM simulation of the enzyme reaction.
    Bellocchi D; Costantino G; Pellicciari R; Re N; Marrone A; Coletti C
    ChemMedChem; 2006 May; 1(5):533-9. PubMed ID: 16892389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.